| ID (ISN) del documento | 55495 |
| Número CIS |
91-671 |
| Año |
1988 |
| Número de serie |
|
| Autor(es) |
Advisory Committee on Dangerous Pathogens |
| Título |
Inactivation of viral haemorrhagic fever specimens with B-propiolactone |
| Información bibliográfica |
Health Services Division 1B, Room A414, Alexander Fleming House, Elephant and Castle, London SE1 6BY, United Kingdom, 1988. 14p. Illus. Bibl. |
| Resumen |
These guidelines describe how heparimised or EDTA treated blood specimens suspected of containing certain haemorrhagic fever viruses may be made safe for examination by inactivation with B propiolactone (BPL). Details are given of the characteristics of BPL and precautions to be taken during its use, and of the effect of BPL inactivation of blood on test results. Kits for blood specimen collection are described and a model information and instruction sheet provided for physicians submitting specimens for inactivation. Details are given of the inactivation procedure and the materials required, and accident procedures are outlined for cases of inoculation accident or spillage. |
| Descriptores (primarios) |
sangre; Reino Unido; riesgos biológicos; enfermedades víricas; servicios médicos y sanitarios; propiolactona |
| Descriptores (secundarios) |
descripción del material; toma de muestras; tratamiento de urgencia; descripción del procedimiento; personal de los servicios de salud; riesgos químicos; hospitales |
| Tipo de documento |
E - Libros, informes, actas |
| País / Estado o Provincia | Reino Unido |
| Tema(s) |
Sustancias tóxicas y peligrosas
|
| Broad subject area(s) |
Riesgos biológicos
|
| Navegación por categoria(s) |
Health care services
Biological hazards
Bacterial and parasitic diseases
Viral diseases (other than aids)
|
